Chaffee Royalties -- An Update!
We revisit three Chaffee Royalty stocks and weigh in on reader mail about portfolio allocations and the differences between the Mayer’s Special Situations and Capital & Crisis portfolios.
Don’t let the next Special Situation pass you by! Chris Mayer logs air miles and meets company insiders so you don’t have to. Join Mayer’s Special Situations and get his latest stock recommendation right away.
Already a subscriber?Login
to get instant access
about this subscription
Other Readers of Mayer's Special Situations Also Benefit From these Articles
After some of the bearish sentiment I told you about on Sunday, let's look long-term for our Momentum Trade of the Week.
I recently had dinner with two prominent biotech venture capitalists I know and trust. We discussed this promising biotech company in our portfolio. Although I made my usual strong case for it, they eventually convinced me that the competition in the field is too powerful to hope for the kind of returns I had expected.
I just got back from the Market Technicians Association's Annual Symposium in New York. Here's everything you need to know about my trip.